Sabra Health Care REIT Inc. (NASDAQ: SBRA) stock fell -0.71% on Friday to $15.37 against a previous-day closing price of $15.48. With 1.74 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.33 million shares. During the session, the REIT – Healthcare Facilities company that operates in wider Real Estate sector, reached to the highest price of $15.70 whereas the lowest price it dropped to was $15.22. The 52-week range on SBRA shows that it touched its highest point at $17.99 and its lowest point at $11.44 during that stretch. It currently has a 1-year price target of $15.22. With its current market cap of 3.48 billion, SBRA has annualized dividend of $1.20 while the current yield stands at 7.81%. Beta for the stock currently stands at 1.34.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SBRA was up-trending over the past week, with a rise of 0.52%, but this was up by 9.79% over a month. Three-month performance surged to 23.26% while six-month performance rose 15.74%. The stock lost -13.46% in the past year, while it has gained 13.52% so far this year. A look at the trailing 12-month EPS for SBRA yields -0.49 with Next year EPS estimates of 0.72. For the next quarter, that number is 0.16. This implies an EPS growth rate of -177.40% for this year and 5.26% for next year. EPS is expected to grow by 7.30% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -20.70%.
Float and Shares Shorts:
At present, 230.86 million SBRA shares are outstanding with a float of 228.03 million shares on hand for trading. On Jul 14, 2022, short shares totaled 13.5 million, which was 5.85% higher than short shares on Jun 14, 2022. In addition to Mr. Richard K. Matros as the firm’s Chairman, Pres & CEO, Mr. Michael Lourenco Costa serves as its Exec. VP, CFO & Sec.
Through their ownership of 88.96% of SBRA’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 53.56% of SBRA, in contrast to 38.59% held by mutual funds. Shares owned by individuals account for 1.59%. As the largest shareholder in SBRA with 15.47% of the stake, The Vanguard Group, Inc. holds 35,738,584 shares worth 35,738,584. A second-largest stockholder of SBRA, BlackRock Fund Advisors, holds 27,104,624 shares, controlling over 11.74% of the firm’s shares. Principal Global Investors LLC is the third largest shareholder in SBRA, holding 17,124,112 shares or 7.41% stake. With a 4.60% stake in SBRA, the Vanguard Real Estate Index Fund is the largest stakeholder. A total of 10,621,497 shares are owned by the mutual fund manager. The Vanguard Total Stock Market Index, which owns about 2.96% of SBRA stock, is the second-largest Mutual Fund holder. It holds 6,844,956 shares valued at 95.62 million. iShares Core S&P Mid Cap ETF holds 2.89% of the stake in SBRA, owning 6,676,394 shares worth 93.27 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2022, SBRA reported revenue of $163.10M and operating income of $68.86M. It generated $40.60M net income for the quarter, which came to -$106.10M over the last twelve months. The EBITDA in the recently reported quarter was $111.39M and diluted EPS was $0.18. EBITDA for the full year was $206.97M.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SBRA since 16 analysts follow the stock currently. There are 7 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 8 believe that the stock is worth HOLDING, 1 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With SBRA analysts setting a high price target of $18.00 and a low target of $14.00, the average target price over the next 12 months is $15.38. Based on these targets, SBRA could surge 17.11% to reach the target high and fall by -8.91% to reach the target low. Reaching the average price target will result in a growth of 0.07% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. SBRA will report FY 2022 earnings on 02/21/2023. Analysts have provided yearly estimates in a range of $0.83 being high and $0.59 being low. For SBRA, this leads to a yearly average estimate of $0.67. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Sabra Health Care REIT Inc. surprised analysts by -$0.09 when it reported $0.07 EPS against a consensus estimate of $0.16. The surprise factor in the prior quarter was $0.03. Based on analyst estimates, the high estimate for the next quarter is $0.22 and the low estimate is $0.14. The average estimate for the next quarter is thus $0.17.
Dividends & Yield:
In terms of dividends, SBRA has a current ratio of $1.2, which is $1.2 over the trailing 12-months, while a dividend of $1.57 is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and SBRA currently yields $7.81. In the past year, SBRA’s dividend yield has been $7.81, but when looking at the stock over the past five years, its yield has been $8.98. Accordingly, SBRA has a current buyback yield of $0.06. This was $0.06 for the TTM.
Summary of Insider Activity:
Insiders traded SBRA stock several times over the past three months with 17 Buys and 0 Sells. In these transactions, 76,232 shares were bought while 0 shares were sold. The number of buy transactions has increased to 58 while that of sell transactions has risen to 6 over the past year. The total number of shares bought during that period was 570,395 while 501,458 shares were sold.